Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-03-13

Clinical Trial Update: A Trial of Stress Reduction in the Secondary Prevention of Coronary Heart Disease in Blacks [Phase 2]

View source ↗

Summary

The document is an update on a Phase 2 clinical trial evaluating stress reduction for secondary prevention in people with coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Maharishi International University | Conditions: Coronary Artery Disease | Phase 2 | Status: UNKNOWN